Beta
322911

Assessment of The Antiviral and Antiproliferation Effects of Kombucha Tea

Article

Last updated: 03 Jan 2025

Subjects

-

Tags

-

Abstract

Kombucha tea (KT) is a traditional non-alcoholic beverage, which is produced from the fermentation of black or green tea with a combination of acetic acid bacteria (AAB) and yeast. In addition to its historical usage in traditional medicine for various ailments, recent studies have demonstrated its potential as anti-cancer and anti-viral agent. Therefore, the objective of this study was to investigate the impact of KT on inducing anti-cancer effects in HepG-2 cells and its potential to exhibit anti-viral activity using Vero cells. MTT assay was conducted to assess the cytotoxicity of the KT and choose the optimal concentration for the study. Three types of cells: Normal human liver cells, HepG-2 cells, and Vero cells treated with KT doses of 10, 25, 50, 100, and 200 mg/ml. The IC50 concentration recorded was 54.87 mg/ ml for HEPG-2 tumor cell line and 73.8 mg/ ml for Vero cells. It was demonstrated that the KT had a strong cytotoxic effect on tumor cells as well as an antiproliferative function.  However, it exhibited no discernible growth inhibition on normal cell lines. Flow cytometry was employed to study the KT's impact on inducing apoptosis (cell death), by exposing the cells to the KT for different periods (24, 48, 72 hours). It was found that KT has the ability to kill cancer-infected cells compared to the control, in early and late apoptosis of 11.27% and 11.01% respectively. The upregulation of the Bax and P53 genes and the downregulation of the Bcl-2 genes were part of the apoptotic process brought on by KT. These results showed that KT had an antiproliferative effect on HepG-2 cells through apoptosis-mediated cytotoxicity and cell cycle blockage at the G2/M phase. Regarding KT antiviral activity, it had a variable activity against different virus models. The percentage of depletion rate compared to its original viral titer recording was 23.1 %, 9.3% and 8.3% for Hepatitis A virus (HAV), rift valley fever virus (RVFV) and Herpes simplex virus (HSV), respectively. These findings imply that KT might be a good natural product therapy for anti-virus and anti-cancer medicines.

DOI

10.21608/eajbsc.2023.322911

Keywords

kombucha, HepG-2, VERO cell, Anticancer activity, antiviral agent

Authors

First Name

Ghada

Last Name

El Nady

MiddleName

H.

Affiliation

Medical Genetic Center, Faculty of Medicine, Ain Shams University.

Email

ghada.elnady@med.asu.edu.eg

City

Egypt

Orcid

0000-0002-4840-3592

First Name

Mona

Last Name

Ibrahim

MiddleName

I. M.

Affiliation

Agricultural Biotechnology Department. Faculty of Biotechnology, Misr University for Science and Technology (MUST).

Email

-

City

Egypt

Orcid

-

First Name

Gamar

Last Name

Gamar

MiddleName

Mahamat

Affiliation

Departme nt of Life and Earth Sciences, Higher N'Djamena Institute For Training Teachers. P.O. Box: 460, N'Djamena, Chad.

Email

-

City

Chad

Orcid

-

First Name

Noha

Last Name

El-Dougdoug

MiddleName

K.

Affiliation

Botany and Microbiology Department, Faculty of Science, Banha University, Banha 13511, Egypt.

Email

-

City

Egypt

Orcid

-

Volume

15

Article Issue

2

Related Issue

42345

Issue Date

2023-12-01

Receive Date

2023-09-16

Publish Date

2023-10-26

Page Start

513

Page End

527

Print ISSN

2090-0767

Online ISSN

2090-083X

Link

https://eajbsc.journals.ekb.eg/article_322911.html

Detail API

https://eajbsc.journals.ekb.eg/service?article_code=322911

Order

322,911

Type

Original Article

Type Code

673

Publication Type

Journal

Publication Title

Egyptian Academic Journal of Biological Sciences. C, Physiology and Molecular Biology

Publication Link

https://eajbsc.journals.ekb.eg/

MainTitle

Assessment of The Antiviral and Antiproliferation Effects of Kombucha Tea

Details

Type

Article

Created At

24 Dec 2024